U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · Real-Time Price · USD
78.29
+0.02 (0.03%)
Aug 27, 2026, 9:40 AM EDT - Market open
U.S. Physical Therapy Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,168 | 1,187 | 1,339 | 1,396 | 1,054 | 1,234 | |
Market Cap Growth | -10.10% | -11.34% | -4.07% | 32.50% | -14.61% | -20.16% |
Enterprise Value | 1,528 | 1,742 | 1,663 | 1,681 | 1,427 | 1,490 |
Last Close Price | 78.27 | 76.61 | 85.00 | 87.60 | 74.89 | 86.74 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 445.83 | 55.04 | 48.29 | 76.95 | 36.00 | 39.61 |
Forward PE | 26.06 | 27.67 | 32.93 | 34.02 | 29.15 | 30.02 |
PS Ratio | 1.45 | 1.54 | 2.02 | 2.33 | 1.92 | 2.52 |
PB Ratio | 2.60 | 1.54 | 1.76 | 2.14 | 2.17 | 2.73 |
P/FCF Ratio | 18.23 | 19.47 | 20.36 | 19.20 | 20.95 | 18.09 |
P/OCF Ratio | 14.06 | 15.82 | 17.87 | 17.03 | 18.00 | 16.15 |
PEG Ratio | 2.33 | 3.27 | 3.86 | 4.61 | 3.24 | 2.50 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.90 | 2.25 | 2.50 | 2.81 | 2.61 | 3.04 |
EV/EBITDA Ratio | 14.97 | 16.90 | 18.76 | 19.68 | 17.68 | 18.12 |
EV/EBIT Ratio | 19.19 | 21.59 | 23.76 | 24.11 | 21.63 | 21.09 |
EV/FCF Ratio | 23.84 | 28.57 | 25.29 | 23.13 | 28.37 | 21.85 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.50 | 0.41 | 0.39 | 0.40 | 0.61 | 0.49 |
Debt / EBITDA Ratio | 2.34 | 1.93 | 2.10 | 1.93 | 2.40 | 1.82 |
Debt / FCF Ratio | 6.02 | 5.17 | 4.49 | 3.56 | 5.87 | 3.27 |
Net Debt / Equity Ratio | 0.47 | 0.36 | 0.33 | 0.16 | 0.54 | 0.43 |
Net Debt / EBITDA Ratio | 3.52 | 2.71 | 2.84 | 1.21 | 3.23 | 2.37 |
Net Debt / FCF Ratio | 5.61 | 4.57 | 3.83 | 1.42 | 5.19 | 2.85 |
Asset Turnover | 0.66 | 0.65 | 0.61 | 0.65 | 0.68 | 0.73 |
Quick Ratio | 1.13 | 0.90 | 1.11 | 2.20 | 1.21 | 1.09 |
Current Ratio | 1.27 | 1.01 | 1.18 | 2.28 | 1.30 | 1.14 |
Return on Equity (ROE) | 6.51% | 7.59% | 6.46% | 6.55% | 9.26% | 13.43% |
Return on Assets (ROA) | 4.10% | 4.25% | 4.04% | 4.70% | 5.13% | 6.57% |
Return on Invested Capital (ROIC) | 5.25% | 5.84% | 6.00% | 7.00% | 7.40% | 9.73% |
Return on Capital Employed (ROCE) | 7.00% | 7.60% | 6.70% | 7.80% | 8.50% | 10.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.23% | 3.33% | 2.35% | 2.02% | 3.05% | 3.31% |
FCF Yield | 5.49% | 5.14% | 4.91% | 5.21% | 4.77% | 5.53% |
Dividend Yield | 2.35% | 2.35% | 2.07% | 1.96% | 2.19% | 1.68% |
Payout Ratio | 1048.07% | 69.13% | 84.46% | 85.44% | 66.30% | 45.96% |
Buyback Yield / Dilution | -0.18% | -0.74% | -6.17% | -9.26% | -0.68% | -0.49% |
Total Shareholder Return | 2.17% | 1.61% | -4.10% | -7.30% | 1.52% | 1.19% |